AlphaFold predicted structure
RRAS2 · P62070

Mean pLDDT
86.7/ 100
Confident
204 residues
Confidence breakdown
- Very high(≥ 90)72%
- Confident(70–90)9%
- Low(50–70)11%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
RAS related 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic short stature
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedRASopathies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial breast cancer
UnknownInherited ovarian cancer (without breast cancer)
UnknownNoonan syndrome
noonan syndrome 12
hereditary disease
neurodegenerative disease
ovarian cancer
vitamin D deficiency
vitamin deficiency disorder
endometrial cancer
hypertrophic cardiomyopathy
breast ductal adenocarcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ras-related protein R-Ras2
GTP-binding protein with GTPase activity, involved in the regulation of MAPK signaling pathway and thereby controlling multiple cellular processes (PubMed:31130282, PubMed:31130285, PubMed:39809765). Regulates craniofacial development (PubMed:31130282, PubMed:31130285)
Curated MONDO disease pages that list RRAS2 among their top associated genes.
RRAS2 · P62070

Mean pLDDT
86.7/ 100
Confident
204 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0